With Ampersand News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the closing of an $18.5.

United statesNoord hollandConnor halversonSteven favaloroPrnewswire genezenDavid andersonContract developmentManufacturing organizationAmpersand capital partnersAmpersand capitalWith ampersandGeneral partner